| Bioactivity | GPX4 activator 2 (Compound C3) is an activator of GPX4. GPX4 activator 2 exhibits cardioprotective effects and can inhibit cellular ferroptosis (EC50 = 7.8 μM)。GPX4 activator 2 can be used in the research of myocardial injury[1]. |
| Target | EC50: 7.8 μM (Ferroptosis). |
| CAS | 950365-31-8 |
| Formula | C20H26N6O2S |
| Molar Mass | 414.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Liu X, et al. GPX4 allosteric activators inhibit ferroptosis and exert myocardial protection in doxorubicin-induced myocardial injury mouse model. Eur J Med Chem. 2024 Jul 30;277:116721. |
GPX4 activator 2
CAS: 950365-31-8 F: C20H26N6O2S W: 414.52
GPX4 activator 2 (Compound C3) is an activator of GPX4. GPX4 activator 2 exhibits cardioprotective effects and can inhib
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.